Prostate Cancer News and Research

Latest Prostate Cancer News and Research

22 pesticides found to be associated with prostate cancer incidence in the United States

Researchers have identified 22 pesticides consistently associated with the incidence of prostate cancer in the United States, with four of the pesticides also linked with prostate cancer mortality.

4 Nov 2024

Quitting smoking after cancer diagnosis can add years to patient lives

Quitting smoking within six months after a cancer diagnosis adds an average of two years to a patient's life.

1 Nov 2024

Weill Cornell Medicine teams receive funding from Starr Cancer Consortium

Three teams led by Weill Cornell Medicine scientists have received awards from the Starr Cancer Consortium in its 17th and final annual grant competition.

30 Oct 2024

AI model could help clinicians to understand prostate tumor's aggressiveness

Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S.

29 Oct 2024

Urine transcriptomics: A new frontier for non-invasive genitourinary disease detection

Researchers explore the potential diagnostic utility of transcriptomic and metabolic signals in the genitourinary system.

29 Oct 2024

Study identifies six cancer susceptibility genes

Identification of six cancer susceptibility genes offers new insights into genetic risk factors, potentially enhancing early detection and treatment strategies.

29 Oct 2024

Study uncovers six cancer susceptibility genes

Scientists at deCODE genetics/Amgen, and their collaborators have discovered six novel genes with rare germline variants that associate with cancer risk. The findings are published today in Nature Genetics under the title "Gene-based burden tests of rare germline variants identify six cancer susceptibility genes".

29 Oct 2024

Space-based research uncovers key to cancer cell survival

In October, we think pink, and for a good reason - one out of every eight women will be diagnosed with breast cancer in their lifetime, and each year, 2 million women are given this frightening diagnosis. Biotechnology startup MicroQuin leveraged the International Space Station (ISS) National Laboratory to grow 3D breast and prostate cancer cell cultures to learn more about how these cancers develop and grow.

29 Oct 2024

New research unveils mechanism behind deadly neuroendocrine prostate cancer

A leading scientist whose discoveries about prostate cancer led to lifesaving treatments is now shedding light on an emerging and deadlier form of the disease: neuroendocrine prostate cancer (NEPC).

28 Oct 2024

Discovery of stem-like CD4 T cells offers new hope for cancer immunotherapy

Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a pivotal role in anti-tumor immunity.

26 Oct 2024

UTEP researchers develop low-cost biochip for cancer diagnosis

Researchers at The University of Texas at El Paso have created a portable device that can detect colorectal and prostate cancer more cheaply and quickly than prevailing methods.

24 Oct 2024

New pro-oxidant supplement shows promise in slowing prostate cancer progression

Prostate cancer is a quiet killer. In most men, it's treatable. However, in some cases, it resists all known therapies and turns extremely deadly.

24 Oct 2024

Semaglutide may lower Alzheimer's risk in type 2 diabetes patients

Researchers at the Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).

24 Oct 2024

New CAR T cells offer controlled treatment for solid tumors

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells - a type of cancer immunotherapy - that can be switched on to varying degrees of intensity and then switched off on demand with existing drugs.

21 Oct 2024

Higher diet quality associated with reduced risk of prostate cancer grade reclassification

A study in JAMA Oncology links dietary quality to prostate cancer grade reclassification risk, suggesting healthier diets may reduce progression in early cases.

21 Oct 2024

Study links healthy diet to reduced progression of low-risk prostate cancer

In a peer-reviewed study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific evidence that a healthy diet may reduce the chance of low risk prostate cancer progressing to a more aggressive state in men undergoing active surveillance - a clinical option in which men with lower risk cancer are carefully monitored for progression in lieu of treatments that could have undesired side effects or complications.

17 Oct 2024

Innovative sensor material offers non-invasive cancer diagnosis

A research team led by Dr. Ho Sang Jung of the Advanced Bio and Healthcare Materials Research Division at the Korea Institute of Materials Science has developed an innovative sensor material that amplifies the optical signals of cancer metabolites in body fluids (saliva, mucus, urine, etc.) and analyzes them using artificial intelligence to diagnose cancer.

17 Oct 2024

Black prostate cancer patients respond better to immunotherapy

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses.

17 Oct 2024

Innovative nanoparticle therapy offers hope in fighting prostate cancer

Prostate cancer is the second leading cause of cancer death among American men.

16 Oct 2024

Early prostate cancer surgery linked to improved survival rates

The survival rate of men with prostate cancer who had their entire prostate gland removed immediately after the tumor was detected increased by 17 percentage points compared with those who did not have treatment until the tumor began to cause symptoms.

10 Oct 2024